NVO → $70.00 by Feb 19, 2026.

1. FDA decision on their glp weight loss oral pill will be coming in Q4. This can be a FDA decision on their glp weight loss oral pill will be coming in Q4. This can be a huge catalyst for a rerating of the stock. They are all but there. 2. They will present phase 3 trial data on Alzheimer's on December 3rd. They are apparently hiring for Alzheimer's roles to be ready to go. Who knows if that's an …